BC008-1A Injection

BC008-1A · Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BC008-1A Injection, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: BC008-1A Injection for Recurrent CNS WHO G4 Glioma [Phase 1]